Exact Sciences (EXAS) Tops Q3 EPS by 23c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. HUM
8. CSCO
9. KTOS
10. NVDA

Go back to Exact Sciences (EXAS) Tops Q3 EPS by 23c

Exact Sciences Announces Third Quarter 2022 Results

November 3, 2022 4:05 PM EDT

Reports Record Revenue, Raises Full-Year Guidance, Accelerates Path to Profitability

Third quarter highlights

Total third quarter revenue, excluding COVID-19 testing, increased 20 percent compared to the third quarter of 2021, with Screening revenue of $361 million and Precision Oncology revenue of $151 millionFull-year revenue guidance raised by $33 million and operating expense guidance lowered by $113 million at the midpointsAdjusted EBITDA profitability now expected in the third quarter of 2023, ahead of previous target of 2024

MADISON, Wis., Nov. 3, 2022 /PRNewswire/... More